J Acad Nutr Diet. 2018 Apr;118(4):555-567. doi: 10.1016/j.jand.2017.07.005. Epub 2017 Sep 12.
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest types of cancer. The worldwide estimates of its incidence and mortality in the general population are eight cases per 100,000 person-years and seven deaths per 100,000 person-years, and they are significantly higher in the United States than in the rest of the world. The incidence of this disease in the United States is more than 50,000 new cases in 2017. Indeed, total deaths due to PDAC are projected to increase dramatically to become the second leading cause of cancer-related deaths before 2030. Considering the failure to date to efficiently treat existing PDAC, increased effort should be undertaken to prevent this disease. A better understanding of the risk factors leading to PDAC development is of utmost importance to identify and formulate preventive strategies. Large epidemiologic and cohort studies have identified risk factors for the development of PDAC, including obesity and type 2 diabetes mellitus. This review highlights the current knowledge of obesity and type 2 diabetes as risk factors for PDAC development and progression, their interplay and underlying mechanisms, and the relation to diet. Research gaps and opportunities to address this deadly disease are also outlined.
胰腺导管腺癌 (PDAC) 是最致命的癌症类型之一。全球普通人群中 PDAC 的发病率和死亡率估计分别为每 10 万人 8 例和每 10 万人 7 例,而在美国的发病率和死亡率均显著高于世界其他地区。2017 年美国 PDAC 的新发病例超过 5 万例。事实上,预计到 2030 年前,PDAC 导致的总死亡人数将大幅增加,成为癌症相关死亡的第二大主要原因。鉴于目前未能有效治疗现有的 PDAC,应加大力度预防这种疾病。更好地了解导致 PDAC 发展的危险因素对于确定和制定预防策略至关重要。大型流行病学和队列研究已经确定了 PDAC 发展的危险因素,包括肥胖和 2 型糖尿病。本综述重点介绍了肥胖和 2 型糖尿病作为 PDAC 发展和进展的危险因素、它们之间的相互作用和潜在机制,以及与饮食的关系。还概述了研究中的空白和解决这一致命疾病的机会。